Presentation during new advances in the management of pancreatic cancer course highlights intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer

Miami & los altos, calif.--(business wire)--renovorx, inc. (nasdaq: rnxt), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its novel therapy platform, renovotamptm (renovorx trans-arterial micro-perfusion), will be highlighted during a presentation by expert panelist, dr. ripal gandhi, at the miami cancer institute's new advances in the management of pancreatic cancer cme course this evening. dr. gandhi, a principal investigator in renovorx's ongoing phase
RNXT Ratings Summary
RNXT Quant Ranking